Exchange Announcement • 05 Dec 2024 07:00
Exchange Announcement • 05 Dec 2024 06:59
Exchange Announcement • 03 Dec 2024 06:46
Exchange Announcement • 15 Nov 2024 14:17
Exchange Announcement • 15 Nov 2024 14:11
ENTITY
Mesoblast Ltd (MSB AU)
Mesoblast Ltd (MSB AU)
46
Analysis
Health Care • Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
x